Literature DB >> 18939808

Nanocrystal core high-density lipoproteins: a multimodality contrast agent platform.

David P Cormode1, Torjus Skajaa, Matti M van Schooneveld, Rolf Koole, Peter Jarzyna, Mark E Lobatto, Claudia Calcagno, Alessandra Barazza, Ronald E Gordon, Pat Zanzonico, Edward A Fisher, Zahi A Fayad, Willem J M Mulder.   

Abstract

High density lipoprotein (HDL) is an important natural nanoparticle that may be modified for biomedical imaging purposes. Here we developed a novel technique to create unique multimodality HDL mimicking nanoparticles by incorporation of gold, iron oxide, or quantum dot nanocrystals for computed tomography, magnetic resonance, and fluorescence imaging, respectively. By including additional labels in the corona of the particles, they were made multifunctional. The characteristics of these nanoparticles, as well as their in vitro and in vivo behavior, revealed that they closely mimic native HDL.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18939808      PMCID: PMC2629801          DOI: 10.1021/nl801958b

Source DB:  PubMed          Journal:  Nano Lett        ISSN: 1530-6984            Impact factor:   11.189


  48 in total

1.  Organic and inorganic nanoparticle hybrids.

Authors:  Nathaniel G Portney; Krishna Singh; Sumit Chaudhary; Giuseppe Destito; Anette Schneemann; Marianne Manchester; Mihrimah Ozkan
Journal:  Langmuir       Date:  2005-03-15       Impact factor: 3.882

Review 2.  Multimodality nanotracers for cardiovascular applications.

Authors:  Willem J M Mulder; David P Cormode; Sjoerd Hak; Mark E Lobatto; Stephane Silvera; Zahi A Fayad
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-08

3.  Integrated magnetic bionanocomposites through nanoparticle-mediated assembly of ferritin.

Authors:  Sudhanshu Srivastava; Bappaditya Samanta; Brian J Jordan; Rui Hong; Qijun Xiao; Mark T Tuominen; Vincent M Rotello
Journal:  J Am Chem Soc       Date:  2007-09-06       Impact factor: 15.419

4.  Nondenaturing polyacrylamide gradient gel electrophoresis.

Authors:  A V Nichols; R M Krauss; T A Musliner
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

5.  Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis.

Authors:  Matthias Nahrendorf; Farouc A Jaffer; Kimberly A Kelly; David E Sosnovik; Elena Aikawa; Peter Libby; Ralph Weissleder
Journal:  Circulation       Date:  2006-09-25       Impact factor: 29.690

6.  Chronic ethanol increases lipopolysaccharide-stimulated Egr-1 expression in RAW 264.7 macrophages: contribution to enhanced tumor necrosis factor alpha production.

Authors:  Liang Shi; Raj Kishore; Megan R McMullen; Laura E Nagy
Journal:  J Biol Chem       Date:  2002-02-20       Impact factor: 5.157

7.  ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.

Authors:  Y Nakashima; A S Plump; E W Raines; J L Breslow; R Ross
Journal:  Arterioscler Thromb       Date:  1994-01

Review 8.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

Authors:  Morteza Naghavi; Peter Libby; Erling Falk; S Ward Casscells; Silvio Litovsky; John Rumberger; Juan Jose Badimon; Christodoulos Stefanadis; Pedro Moreno; Gerard Pasterkamp; Zahi Fayad; Peter H Stone; Sergio Waxman; Paolo Raggi; Mohammad Madjid; Alireza Zarrabi; Allen Burke; Chun Yuan; Peter J Fitzgerald; David S Siscovick; Chris L de Korte; Masanori Aikawa; K E Juhani Airaksinen; Gerd Assmann; Christoph R Becker; James H Chesebro; Andrew Farb; Zorina S Galis; Chris Jackson; Ik-Kyung Jang; Wolfgang Koenig; Robert A Lodder; Keith March; Jasenka Demirovic; Mohamad Navab; Silvia G Priori; Mark D Rekhter; Raymond Bahr; Scott M Grundy; Roxana Mehran; Antonio Colombo; Eric Boerwinkle; Christie Ballantyne; William Insull; Robert S Schwartz; Robert Vogel; Patrick W Serruys; Goran K Hansson; David P Faxon; Sanjay Kaul; Helmut Drexler; Philip Greenland; James E Muller; Renu Virmani; Paul M Ridker; Douglas P Zipes; Prediman K Shah; James T Willerson
Journal:  Circulation       Date:  2003-10-07       Impact factor: 29.690

9.  Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging.

Authors:  Patrick M Winter; Shelton D Caruthers; Andrea Kassner; Thomas D Harris; Lori K Chinen; John S Allen; Elizabeth K Lacy; Huiying Zhang; J David Robertson; Samuel A Wickline; Gregory M Lanza
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

Review 10.  Multimodal MRI contrast agents.

Authors:  Luca Frullano; Thomas J Meade
Journal:  J Biol Inorg Chem       Date:  2007-07-21       Impact factor: 3.862

View more
  125 in total

1.  The biological properties of iron oxide core high-density lipoprotein in experimental atherosclerosis.

Authors:  Torjus Skajaa; David P Cormode; Peter A Jarzyna; Amanda Delshad; Courtney Blachford; Alessandra Barazza; Edward A Fisher; Ronald E Gordon; Zahi A Fayad; Willem J M Mulder
Journal:  Biomaterials       Date:  2011-01       Impact factor: 12.479

Review 2.  Nanoparticle systems for cancer vaccine.

Authors:  Ru Wen; Afoma C Umeano; Yi Kou; Jian Xu; Ammad Ahmad Farooqi
Journal:  Nanomedicine (Lond)       Date:  2019-02-26       Impact factor: 5.307

Review 3.  Emerging applications of nanotechnology for the diagnosis and management of vulnerable atherosclerotic plaques.

Authors:  Shann S Yu; Ryan A Ortega; Brendan W Reagan; John A McPherson; Hak-Joon Sung; Todd D Giorgio
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2011-08-10

4.  Lipid-Mediated Targeting with Membrane-Wrapped Nanoparticles in the Presence of Corona Formation.

Authors:  Fangda Xu; Michael Reiser; Xinwei Yu; Suryaram Gummuluru; Lee Wetzler; Björn M Reinhard
Journal:  ACS Nano       Date:  2016-01-06       Impact factor: 15.881

Review 5.  High-Density Lipoproteins: Nature's Multifunctional Nanoparticles.

Authors:  Rui Kuai; Dan Li; Y Eugene Chen; James J Moon; Anna Schwendeman
Journal:  ACS Nano       Date:  2016-02-25       Impact factor: 15.881

Review 6.  Nanoparticles for Cardiovascular Imaging and Therapeutic Delivery, Part 1: Compositions and Features.

Authors:  John C Stendahl; Albert J Sinusas
Journal:  J Nucl Med       Date:  2015-08-13       Impact factor: 10.057

Review 7.  Nanoparticles for concurrent multimodality imaging and therapy: the dawn of new theragnostic synergies.

Authors:  Giovanni Lucignani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-05       Impact factor: 9.236

8.  Dextran coated bismuth-iron oxide nanohybrid contrast agents for computed tomography and magnetic resonance imaging.

Authors:  Pratap C Naha; Ajlan Al Zaki; Elizabeth Hecht; Michael Chorny; Peter Chhour; Eric Blankemeyer; Douglas M Yates; Walter R T Witschey; Harold I Litt; Andrew Tsourkas; David P Cormode
Journal:  J Mater Chem B       Date:  2014-12-14       Impact factor: 6.331

Review 9.  Modified natural nanoparticles as contrast agents for medical imaging.

Authors:  David P Cormode; Peter A Jarzyna; Willem J M Mulder; Zahi A Fayad
Journal:  Adv Drug Deliv Rev       Date:  2009-11-06       Impact factor: 15.470

10.  Nanomedicines for Endothelial Disorders.

Authors:  Bomy Lee Chung; Michael J Toth; Nazila Kamaly; Yoshitaka J Sei; Jacob Becraft; Willem J M Mulder; Zahi A Fayad; Omid C Farokhzad; YongTae Kim; Robert Langer
Journal:  Nano Today       Date:  2015-12-01       Impact factor: 20.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.